{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:58:36Z","timestamp":1773291516402,"version":"3.50.1"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,11,11]],"date-time":"2010-11-11T00:00:00Z","timestamp":1289433600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1471-2377-10-113","type":"journal-article","created":{"date-parts":[[2010,11,11]],"date-time":"2010-11-11T07:15:43Z","timestamp":1289459743000},"source":"Crossref","is-referenced-by-count":30,"title":["Expression of chemokine receptors on peripheral blood lymphocytes in multiple sclerosis and neuromyelitis optica"],"prefix":"10.1186","volume":"10","author":[{"given":"Akiyuki","family":"Uzawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Mori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sei","family":"Hayakawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saeko","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumio","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Kuwabara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,11,11]]},"reference":[{"key":"394_CR1","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1056\/NEJM199802123380706","volume":"338","author":"AD Luster","year":"1998","unstructured":"Luster AD: Chemokines-chemotactic cytokines that mediate inflammation. N Engl J Med. 1998, 338: 436-45. 10.1056\/NEJM199802123380706.","journal-title":"N Engl J Med"},{"key":"394_CR2","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1172\/JCI5150","volume":"103","author":"TL S\u00f8rensen","year":"1999","unstructured":"S\u00f8rensen TL, Tani M, Jensen J, Pierce V, Lucchinetti C, Folcik VA, Qin S, Rottman J, Sellebjerg F, Strieter RM, Frederiksen JL, Ransohoff RM: Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J Clin Invest. 1999, 103: 807-15. 10.1172\/JCI5150.","journal-title":"J Clin Invest"},{"key":"394_CR3","doi-asserted-by":"publisher","first-page":"6873","DOI":"10.1073\/pnas.96.12.6873","volume":"96","author":"KE Balashov","year":"1999","unstructured":"Balashov KE, Rottman JB, Weiner HL, Hancock WW: CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc Natl Acad Sci USA. 1999, 96: 6873-8. 10.1073\/pnas.96.12.6873.","journal-title":"Proc Natl Acad Sci USA"},{"key":"394_CR4","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0165-5728(00)00456-2","volume":"114","author":"T Misu","year":"2001","unstructured":"Misu T, Onodera H, Fujihara K, Matsushima K, Yoshie O, Okita N, Takase S, Itoyama Y: Chemokine receptor expression on T cells in blood and cerebrospinal fluid at relapse and remission of multiple sclerosis: imbalance of Th1\/Th2-associated chemokine signaling. J Neuroimmunol. 2001, 114: 207-12. 10.1016\/S0165-5728(00)00456-2.","journal-title":"J Neuroimmunol"},{"key":"394_CR5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1093\/intimm\/11.1.81","volume":"11","author":"T Imai","year":"1999","unstructured":"Imai T, Nagira M, Takagi S, Kakizaki M, Nishimura M, Wang J, Gray PW, Matsushima K, yoshie O: Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine. Int Immunol. 1999, 11: 81-8. 10.1093\/intimm\/11.1.81.","journal-title":"Int Immunol"},{"key":"394_CR6","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1212\/01.wnl.0000216139.44259.74","volume":"66","author":"DM Wingerchuk","year":"2006","unstructured":"Wingerchuk DM, Lennon VA, Pittock SJ, Lucchinetti CF, Weinshenker BG: Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006, 66: 1485-9. 10.1212\/01.wnl.0000216139.44259.74.","journal-title":"Neurology"},{"key":"394_CR7","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1084\/jem.20050304","volume":"202","author":"VA Lennon","year":"2005","unstructured":"Lennon VA, Kryzer TJ, Pittock SJ, Verkman AS, Hinson SR: IgG marker of optic-spinal multiple sclerosis binds to the aquaporin-4 water channel. J Exp Med. 2005, 202: 473-7. 10.1084\/jem.20050304.","journal-title":"J Exp Med"},{"key":"394_CR8","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1093\/brain\/awl371","volume":"130","author":"SF Roemer","year":"2007","unstructured":"Roemer SF, Parisi JE, Lennon VA, Benarroch EE, Lassmann H, Bruck W, Mandler RN, Weinshenker BG, Pittock SJ, Wingerchuk DM, Lucchinetti CF: Pattern-specific loss of aquaporin-4 immunoreactivity distinguishes neuromyelitis optica from multiple sclerosis. Brain. 2007, 130: 1194-205. 10.1093\/brain\/awl371.","journal-title":"Brain"},{"key":"394_CR9","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1002\/ana.21753","volume":"66","author":"S Ito","year":"2009","unstructured":"Ito S, Mori M, Makino T, Hayakawa S, Kuwabara S: \"Cloud-like enhancement\" is a magnetic resonance imaging abnormality specific to neuromyelitis optica. Ann Neurol. 2009, 66: 425-8. 10.1002\/ana.21753.","journal-title":"Ann Neurol"},{"key":"394_CR10","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1093\/brain\/awh453","volume":"128","author":"T Ishizu","year":"2005","unstructured":"Ishizu T, Osoegawa M, Mei FJ, Kikuchi H, Tanaka M, Takakura Y, Minohara M, Murai H, Mihara F, Taniwaki T, Kira J: Intrathecal activation of the IL-17\/IL-8 axis in opticospinal multiple sclerosis. Brain. 2005, 128: 988-1002. 10.1093\/brain\/awh453.","journal-title":"Brain"},{"key":"394_CR11","doi-asserted-by":"publisher","first-page":"2082","DOI":"10.1007\/s00415-009-5274-4","volume":"256","author":"A Uzawa","year":"2009","unstructured":"Uzawa A, Mori M, Ito M, Uchida T, Hayakawa S, Masuda S, Kuwabara S: Markedly increased CSF interleukin-6 levels in neuromyelitis optica, but not in multiple sclerosis. J Neurol. 2009, 256: 2082-4. 10.1007\/s00415-009-5274-4.","journal-title":"J Neurol"},{"key":"394_CR12","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1111\/j.1468-1331.2009.02897.x","volume":"17","author":"A Uzawa","year":"2010","unstructured":"Uzawa A, Mori M, Hayakawa S, Masuda S, Kuwabara S: Different responses to interferon beta-1b treatment in patients with neuromyelitis optica and multiple sclerosis. Eur J Neurol. 2010, 17: 672-6. 10.1111\/j.1468-1331.2009.02897.x.","journal-title":"Eur J Neurol"},{"key":"394_CR13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.jneuroim.2008.03.009","volume":"196","author":"S Hayakawa","year":"2008","unstructured":"Hayakawa S, Mori M, Okuta A, Kamegawa A, Fujiyoshi Y, Mitsuoka K, Ishibashi K, Sasaki S, Hattori T, Kuwabara S: Neuromyelitis optica and anti-aquaporin-4 antibodies measured by an enzyme-linked immunosorbent assay. J Neuroimmunol. 2008, 196: 181-7. 10.1016\/j.jneuroim.2008.03.009.","journal-title":"J Neuroimmunol"},{"key":"394_CR14","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/ana.1032","volume":"50","author":"WI McDonald","year":"2001","unstructured":"McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, Sandberg-Wollheim M, Sibley W, Thompson A, van den Noort S, Weinshenker BY, Wolinsky JS: Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol. 2001, 50: 121-7. 10.1002\/ana.1032.","journal-title":"Ann Neurol"},{"key":"394_CR15","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1084\/jem.187.1.129","volume":"187","author":"R Bonecchi","year":"1998","unstructured":"Bonecchi R, Bianchi G, Bordignon PP, D'Ambrosio D, Lang R, Borsatti A, Sozzani S, Allavena P, Gray PA, Mantovani A, Sinigaglia F: Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J Exp Med. 1998, 187: 129-34. 10.1084\/jem.187.1.129.","journal-title":"J Exp Med"},{"key":"394_CR16","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/S0022-510X(00)00322-1","volume":"177","author":"XM Wu","year":"2000","unstructured":"Wu XM, Osoegawa M, Yamasaki K, Kawano Y, Ochi H, Horiuchi I, Minohara M, Ohyagi Y, Yamada T, Kira JI: Flow cytometric differentiation of Asian and Western types of multiple sclerosis, HTLV-1-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) and hyperIgEaemic myelitis by analyses of memory CD4 positive T cell subsets and NK cell subsets. J Neurol Sci. 2000, 177: 24-31. 10.1016\/S0022-510X(00)00322-1.","journal-title":"J Neurol Sci"},{"key":"394_CR17","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/S0022-510X(03)00214-4","volume":"216","author":"HY Wang","year":"2003","unstructured":"Wang HY, Matsui M, Araya S, Onai N, Matsushima K, Saida T: Immune parameters associated with early treatment effects of high-dose intravenous methylprednisolone in multiple sclerosis. J Neurol Sci. 2003, 216: 61-6. 10.1016\/S0022-510X(03)00214-4.","journal-title":"J Neurol Sci"},{"key":"394_CR18","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1189\/jlb.1205725","volume":"80","author":"N Kobayashi","year":"2006","unstructured":"Kobayashi N, Kondo T, Takata H, Yokota S, Takiguchi M: Functional and phenotypic analysis of human memory CD8+ T cells expressing CXCR3. J Leukoc Biol. 2006, 80: 320-9. 10.1189\/jlb.1205725.","journal-title":"J Leukoc Biol"},{"key":"394_CR19","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1002\/eji.200939314","volume":"39","author":"Z Shi","year":"2009","unstructured":"Shi Z, Okuno Y, Rifa'i M, Endharti AT, Akane K, Isobe K, Suzuki H: Human CD8+CXCR3+ T cells have the same function as murine CD8+CD122+ Treg. Eur J Immunol. 2009, 39: 2106-19. 10.1002\/eji.200939314.","journal-title":"Eur J Immunol"},{"key":"394_CR20","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jneuroim.2003.12.010","volume":"149","author":"K Narikawa","year":"2004","unstructured":"Narikawa K, Misu T, Fujihara K, Nakashima I, Sato S, Itoyama Y: CSF chemokine levels in relapsing neuromyelitis optica and multiple sclerosis. J Neuroimmunol. 2004, 149: 182-6. 10.1016\/j.jneuroim.2003.12.010.","journal-title":"J Neuroimmunol"},{"key":"394_CR21","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/brain\/awp309","volume":"133","author":"S Saadoun","year":"2010","unstructured":"Saadoun S, Waters P, Bell BA, Vincent A, Verkman AS, Papadopoulos MC: Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. Brain. 2010, 133: 349-61. 10.1093\/brain\/awp309.","journal-title":"Brain"},{"key":"394_CR22","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1111\/j.1600-0404.2005.00566.x","volume":"113","author":"I Elovaara","year":"2006","unstructured":"Elovaara I, Kuusisto H, Paalavuo R, S\u00e4rkij\u00e4rvi S, Lehtim\u00e4ki T, Huhtala H, Vilpo J: Effect of high-dose methylprednisolone treatment on CCR5 expression on blood cells in MS exacerbation. Acta Neurol Scand. 2006, 113: 163-6. 10.1111\/j.1600-0404.2005.00566.x.","journal-title":"Acta Neurol Scand"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-10-113.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2377-10-113\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2377-10-113","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,7,14]],"date-time":"2016-07-14T22:05:41Z","timestamp":1468533941000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcneurol.biomedcentral.com\/articles\/10.1186\/1471-2377-10-113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,11]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["394"],"URL":"https:\/\/doi.org\/10.1186\/1471-2377-10-113","relation":{},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,11]]},"article-number":"113"}}